Evaluation of the Long-Term Health Outcomes of Ledipasivir/Sofosbuvir (LDV/SOF) and Sofosbuvir-based Regimens for Patients With Chronic Hepatitis C (CHC) And Liver Cirrhosis Across Genotypes 1 to 4 (GT 1-4): Results from a Decision-Analytic Markov Model

被引：0
|
作者：
Gordon, Stuart C. [1 ]
Ahmed, Aijaz [2 ]
Saab, Sammy [3 ]
Younossi, Zobair [4 ]
机构：
[1] Henry Ford Hosp, Detroit, MI 48202 USA
[2] Stanford Univ, Med Ctr, Stanford, CA 94305 USA
[3] Univ Calif Los Angeles, Los Angeles, CA USA
[4] Inova Hlth Syst, Falls Church, VA USA
来源：
HEPATOLOGY | 2014年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1750
引用
收藏
页码：1040A / 1041A
页数：2
相关论文
共 9 条
  • [1] A Decision-Analytic Markov Model To Evaluate The Health Outcomes of Ledipasvir/Sofosbuvir (LDV/SOF) for Patients with Chronic Hepatitis C (HCV) Genotype 1 (GT1) Infection
    Younossi, Zobair
    Saab, Sammy
    Ahmed, Aijaz
    Gordon, Stuart C.
    HEPATOLOGY, 2014, 60 : 1043A - 1043A
  • [2] A Decision Analytic Markov Model to Evaluate the Health Outcomes of Sofosbuvir/Velpatasvir for Patients with Chronic Hepatitis C Virus Genotypes 1 to 6 and Decompensated Cirrhosis in the US
    Ahmed, Aijaz
    Saab, Sammy
    Gordon, Stuart C.
    Dieterich, Douglas T.
    Wong, Robert J.
    Brown, Kimberly Ann
    Kugelmas, Marcelo
    Younossi, Zobair M.
    HEPATOLOGY, 2016, 64 : 418A - 418A
  • [3] LONG-TERM OUTCOMES OF LEDIPASVIR/SOFOSBUVIR (LDV/ SOF) FOR THE TREATMENT OF CHRONIC HEPATITIS C INFECTED (HCV) GENOTYPE 1 PATIENTS IN THE UK
    Guerra, I
    Marie, L.
    Cure, S.
    VALUE IN HEALTH, 2014, 17 (07) : A675 - A675
  • [4] A Decision Analytic Markov Model to Evaluate the Health Outcomes of Sofosbuvir for Previously Untreated Patients with Chronic Hepatitis C Virus Genotype 1 Infection
    Younossi, Zobair M.
    Gordon, Stuart C.
    Saab, Sammy
    Ahmed, Aijaz
    Brogan, Anita
    Cure, Sandrine
    HEPATOLOGY, 2013, 58 : 387A - 388A
  • [5] A Decision Analytic Markov Model to Evaluate the Health Outcomes of Sofosbuvir/Velpatasvir for Patients with Chronic Hepatitis C Virus Genotype 1 Infection in the US
    Younossi, Zobair M.
    Gordon, Stuart C.
    Dieterich, Douglas T.
    Wong, Robert
    Brown, Kimberly Ann
    Kugelmas, Marcelo
    Saab, Sammy
    Ahmed, Aijaz
    HEPATOLOGY, 2016, 64 : 421A - 422A
  • [6] Evaluation of the Health Outcomes for Ledipasvir/Sofosbuvir in Early vs. Delayed Treatment According to Fibrosis Stage of Patients with Chronic Hepatitis C Virus (HCV) Genotype 1 Infection: Results from a Decision-Analytic Markov Model
    Ahmed, Aijaz
    Gordon, Stuart C.
    Saab, Sammy
    Younossi, Zobair
    HEPATOLOGY, 2014, 60 : 1041A - 1041A
  • [7] Treatment with Interferon (IFN) and Ribavirin (RBV)-Free Regimens with Ledipasvir (LDV) and Sofosbuvir (SOF) Improves Patient-Reported Outcomes (PRO) for Patients with Genotype 1 (GT1) Chronic Hepatitis C (CH-C): Results from the ION-1,2 and 3 Clinical Trials
    Younossi, Zobair
    Stepanova, Maria
    Marcellin, Patrick
    Afdhal, Nezam H.
    Kowdley, Kris V.
    Zeuzem, Stefan
    Hunt, Sharon L.
    HEPATOLOGY, 2014, 60 : 235A - 236A
  • [8] IMPRESSIVE GAINS IN PATIENT-REPORTED OUTCOMES ARE OBSERVED IN CHRONIC HEPATITIS C PATIENTS WITH OR WITHOUT CIRRHOSIS WHO ARE TREATED WITH SOFOSBUVIR AND VELPATASVIR: RESULTS FROM ASTRAL-1,-2,-3 AND-4
    Younossi, Z. M.
    Stepanova, M.
    Feld, J.
    Zeuzem, S.
    Sulkowski, M.
    Foster, G. R.
    Mangia, A.
    Charlton, M.
    O'Leary, J. G.
    Curry, M. P.
    Hunt, S.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S629 - S629
  • [9] SIMEPREVIR (SMV) PLUS DACLATASVIR (DCV) AND SOFOSBUVIR (SOF) IN TREATMENT-NAIVE AND -EXPERIENCED PATIENTS WITH CHRONIC HEPATITIS C VIRUS GENOTYPE 1 OR 4 INFECTION AND DECOMPENSATED LIVER DISEASE: INTERIM RESULTS FROM THE PHASE II IMPACT STUDY
    Lawitz, E.
    Poordad, F.
    Gutierrez, J.
    Kakuda, T.
    Picchio, G.
    De La Rosa, G.
    Beets, G.
    Vandevoorde, A.
    Van Remoortere, P.
    Jacquemyn, B.
    Quinn, G.
    Luo, D.
    Ouwerkerk-Mahadevan, S.
    Vijgen, L.
    Van Eygen, V.
    Beumont, M.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S266 - S267
1